Journal article
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
Abstract
BACKGROUND: Weight loss in chronic heart failure is linked to impaired survival. We aimed to assess the frequency of weight loss in patients with this disease, whether the degree of weight loss predicts mortality, and whether weight loss can be prevented by angiotensin-converting-enzyme (ACE) inhibitors.
METHODS: We investigated weight changes in 1929 patients from the SOLVD trial who had chronic heart failure, were free of oedema at baseline, …
Authors
Anker SD; Negassa A; Coats AJ; Afzal R; Poole-Wilson PA; Cohn JN; Yusuf S
Journal
The Lancet, Vol. 361, No. 9363, pp. 1077–1083
Publisher
Elsevier
Publication Date
3 2003
DOI
10.1016/s0140-6736(03)12892-9
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAngiotensin-Converting Enzyme InhibitorsChronic DiseaseData Interpretation, StatisticalDouble-Blind MethodDrug Therapy, CombinationEnalaprilFemaleFollow-Up StudiesHeart FailureHumansHydralazineIsosorbide DinitrateMaleMiddle AgedPrognosisRandomized Controlled Trials as TopicSurvival AnalysisWeight Loss